Building Radio frequency IDentification solutions for the Global Environment - PowerPoint PPT Presentation

1 / 63
About This Presentation
Title:

Building Radio frequency IDentification solutions for the Global Environment

Description:

Mass serialisation needed to trace to item level ... Mass serialisation and the granularity it provides strengthens the Business Case ... – PowerPoint PPT presentation

Number of Views:61
Avg rating:3.0/5.0
Slides: 64
Provided by: andrew432
Category:

less

Transcript and Presenter's Notes

Title: Building Radio frequency IDentification solutions for the Global Environment


1
Building Radio frequency IDentification
solutionsfor the Global Environment
  • BRIDGE - Pharma Traceability Pilot
  • Project Overview

2
Outline
  • About the BRIDGE project
  • Outline of the Pharma Traceability Pilot
  • Pilot Objectives
  • The Project Partners
  • Major Achievements Deliverables
  • Lessons learned and experiences gained
  • Conclusions and recommendations
  • Summary

3
BRIDGEBuilding Radio frequency IDentification
solutionsfor the Global Environment
  • a project funded by the European Union

4
The BRIDGE Project
  • The objective is to do the necessary research and
    actions to facilitate the implementation of
    EPCglobal in Europe. The project will link pilot
    implementations in various sectors with Research
    and Development.

Pharma traceability
SC mgt textiles
Manufacturing process
Re-usable assets
Products in service
Tagging non-food items
anti counterfeiting
B R I D G E
hardware
lookup service
supply chain control
security
training e-learning
adoption tools
5
BRIDGE PartnersNote WP6 Partners shown in bold

6
The Pharma Traceability PilotOutline of the
Pilot
7
What are the key issues?
  • Medication errors
  • Mis-identification of medicines
  • Harm and death to patients
  • The growing and imminent threat of counterfeit
    medicines
  • for branded and generic products
  • Significant threats to
  • Patient safety
  • Trust in safety of medicines
  • Supply chain inefficiency
  • Lack of automation
  • too much administrative overhead
  • Multi-application requirement

8
Pharma Traceability Pilot end to end
traceability
  • Full supply chain traceability
  • From point of manufacture to point of use
  • i.e. From the manufacturers production line to
    hospital Goods In
  • Mass serialisation - track and trace to the item
    (patient pack) level
  • Product code serial number (SGTIN), batch
    number, expiry date (4 string dataset)
  • Case and Pallet uniquely identified
  • Data aggregation pack to case to pallet
  • Product and trading partner authentication at
    each node in the chain
  • Transparency and common standards are key
  • Distributed database (the EPC Network
    architecture) as the information repository
  • Data carrier independent
  • A common dataset across data carriers
  • Mix of linear, 2-D Data Matrix and RFID/EPC tags
  • For all levels of packaging (patient pack, case,
    pallet)

9
High level objectives
  • Implement a complete supply chain traceability
    system for pharma products in a real life
    operational environment
  • Inline coding, marking, QA for all levels of
    product packaging
  • Multi-application support capability e.g.
  • Electronic pedigree, Product authentication,
    Recall, Inventory management, Financial
    reconciliation
  • Demonstrate a business case and feasibility, cost
    efficiency, and interoperability of the
    technology suite, regardless of
  • Pharma product packaging level and and product
    type
  • Serialised data tag (RFID and/or Data Matrix
    code)
  • Full supply chain representation
  • Compliant with open standards (GS1)
  • Speed to result (24 month timeframe)
  • Easy to use, robust system
  • Project transparency open to all

10
Pharma Traceability Pilote-Traceability
enabling multiple applications
Distributor
Wholesaler
3PL
Contract Packer
Carrier
Traceability kernel
Manufacturer
Hospital Pharmacy
Application interface
Inventorymanagement
Application environment
Authentication
Electronic Pedigree(anti-counterfeit)
Recall
Financial reconciliation
11

PRIMARY
SECONDARY
TERTIARY
12
AUTHENTICATION
MANUFACTURING
DISTRIBUTION
LOGISITICS
PHARMACY
IDENTIFICATION
information collection via
SYNCHRONISATION
INFORMATIONANALYSIS SUBSCRIPTION
13
Access to the EPCglobal service collecting
traceability data
  • Each user had a hardware/software standalone
    system that provided easy (internet-based)
    access to the EPCglobal system
  • EPCIS instances provided and hosted by VeriSign
    Inc.
  • Incoming and outgoing products scanned/read by
    appropriate equipment thereby collecting the
    traceability data
  • Fixed and mobile scanning technology
  • Easy to use screen-based systems

14
Pharma Traceability Pilot participantssolution
and technology suppliers
Provision and deployment of the inline equipment
and printing solution
Provision of standards and RFID consultancy
Project management, business consulting
marketing
Technical design and software development
EPCIS database provision
15
Our User Community
  • Manufacturers
  • Actavis (UK)
  • Athlone Laboratories (Ireland)
  • Sandoz (UK)
  • Contract packer
  • Tjoapack (The Netherlands)
  • Pre-wholesaler
  • CPG Logistics (UK)
  • Distributor/Storage
  • Actavis (UK)
  • Kent Pharmaceuticals (UK)
  • Transport Logistics
  • Movianto (integrated) and others
  • Wholesaler
  • UniChem (UK)
  • Hospital
  • Barts and The London NHS Trust (UK)

KENT
Pharmaceuticals
Our sincere thanks to them all!
16
Pharma Traceability PilotAchievements and
Deliverables
17
Major Achievements (1)
  • Nine supply chain end users recruited
  • Across Ireland, Netherlands and UK
  • 19 product lines selected
  • one years pharmacy stock ordered and manufactured
  • Different packs and forms, includes 2 controlled
    drugs
  • Production line encoding/printing equipment
    specified, acquired, configured and installed at
    Contract Packer and one Manufacturer
  • Application software specified, developed and
    QAd
  • 4 modules manufacturers, distributors,
    wholesaler pharmacy
  • User briefings, interviews (e.g. Business Case
    input), internal process flow analysis, supply
    chain model - all completed and agreed

18
Major Achievements (2)
  • Audio Visual of the pilot experiences (user
    interviews, processes) commissioned and filming
    undertaken
  • Extensive publicity / promotion achieved (e.g.
    media conference platforms) network of
    interested parties established (over 130
    organisations)
  • Pilot preparations procedures, processes, IT
    equipment provision all completed
  • Product runs of marking/encoding completed 15
    product lines distributed downstream to UniChem
  • 17 product lines successfully encoded on the line
  • Preparations for the pilot operation undertaken
    training, documentation, support processes
  • Operational pilot commenced October 2007
    completed end May 2008
  • Including order/replenishment process, Barts /
    UniChem
  • Considerable traceability data collected (inc GPS
    based)
  • Full analysis undertaken

19
Pilot Products 19 lines
Product Form Pack   Aqueous Cream
500mg Tubs 1 Warfarin 1/3/5mg Tabs 28 Clind
amycin 150mg Caps 24 Dihydrocodeine
30mg Tabs 28 Prednisilone E/C
5mg Tabs 28 Co-Codamol 8/500mg Tabs 30 Fluc
loxacillin 250 / 500mg Caps 28 Penicillin V
250mg abs 28 Amoxicillin 125 /
250mg Susp/Sugar Free 100ml Amoxicillin 250 /
500mg Caps 21 Penicillin 125 / 250 mg
Susp/Sugar Free 100ml Flucloxac
illin 125 / 250mg Susp 100ml
controlled substances
20
Promotion and Publicity
  • Contact Database now over 130 organisations
  • Project has been presented in many conferences /
    meetings all around Europe e.g. Helsinki,
    Amsterdam, Brussels, Dublin, London, Dusseldorf,
    Cambridge, Cork
  • Significant interest from media
  • Latest Irish Times, RFID Journals of US and
    Spain
  • Regular update newsletters distributed to over
    130 organisations globally
  • WP13 animated story board developed
  • AV based case study produced
  • the process, action shots, user interviews

21
WP6 Deliverables (1)
  • Key conclusions
  • Improving patient safety is the No. 1 priority
    for all players
  • Medication error is one of the most significant
    hazards
  • Counterfeit threat exacerbates the risk
  • Supply chain inefficiency creates significant
    overheads
  • End to end traceability supported by Bar Code and
    RFID technologiesoffers significant benefits for
    not only patient safety but multiple other
    applications

See http//www.bridge-project.eu/index.php/Publ
ic20Deliverables/en/
22
WP6 Deliverables (2)
  • Key conclusions
  • Track and trace is the critical element
  • Mass serialisation needed to trace to item level
  • Industry supported carriers e.g. Data Matrix, as
    well as RFID at higher levels of packaging
  • Product code, serial number, expiry date and
    batch number data elements
  • Use of GS1 standard keys adds to completeness of
    traceability system
  • EPC Network offers information access and
    visibility for all parties
  • Requirement is broader than just pedigree
    financial reconciliation, inventory management,
    product recall, authentication are all key, all
    enabled by the traceability application.

See http//www.bridge-project.eu/index.php/Publ
ic20Deliverables/en/
23
WP6 Deliverables (3)
  • Key conclusions
  • Patient safety is the most significant benefit
    for all parties- but how can one value peoples
    lives in a financial model?
  • Mass serialisation and the granularity it
    provides strengthens the Business Case
  • Financial benefits of cost reduction, efficiency
    gains, opportunities for additional revenue and
    cash generation ability to respond faster to
    regulatory changes
  • Level of benefits depends upon supply chain role
    and extent of integrationwith internal and
    supply chain systems

See http//www.bridge-project.eu/index.php/Publ
ic20Deliverables/en/
24
WP6 Deliverables (4)
  • Key conclusions
  • Hardware solution outline - EPCglobal Network,
    coding and tagging by laser and inline inkjet
    printing, Class 1 Gen 2 UHF tags, Data Matrix
    codes, various inline data verification
    equipment,
  • Software solution - web based software
    manufacturer, distributor, wholesaler, pharmacy
    modules
  • GPS tracking system for additional pallet level
    security
  • User pilot process defined, installation and user
    training
  • Pilot product processes defined
  • Performance and evaluation processes
  • Pilot operations
  • Promotion and publicity plans

See http//www.bridge-project.eu/index.php/Publ
ic20Deliverables/en/
25
WP6 Deliverables (5)
  • Key conclusions
  • Pilot Operation Phase
  • - all development, installation training
    completed
  • - 17 of the 19 products successfully encoded /
    marked
  • all products shipped tracked (inc GPS) to
    UniChem (by early 2008)
  • order/replenishment cycle (Barts to UniChem)
    completed end May
  • all RFID data matrix traceability data
    collected (for analysis, ongoing)
  • traceability system operated satisfactorily
  • all key activities filmed for promotional AV
    (for Dissemination phase)
  • work commenced to establish Centre of Excellence
    (in The Netherlands)
  • based on Bridge experience

See http//www.bridge-project.eu/index.php/Publ
ic20Deliverables/en/
26
WP6 Deliverables (6)
  • Key conclusions
  • Full supply chain traceability, end to end, is
    feasible with technologies available today
  • Inline printing and marking of products at all
    levels of packaging is possible now at production
    line speeds
  • Hybrid data carriers Data Matrix RFID,
    supporting 4 element data string and data
    collected via EPCIS architecture, supported by
    GS1 Standards, operates most effectively
  • Positive Business Case regardless of supply chain
    function although the degree varies
  • Multi-application support, including encoding of
    batch number and expiry date, broadens
    attractiveness of the business case
  • Wholesaler automation of high-speed tote assembly
    process for traceability recording requires
    further investigation
  • Consideration necessary when designing packaging
    for appropriate placement of Data Matrix codes

27
WP6 Deliverables (7)
  • Key conclusions
  • IN DEVELOPMENT NOW

28
Supply Chain Modelthe manufacturing and storage
cycle
29
Supply chain mapcustomer delivery cycle
Manufacturing Distribution, Storage
Wholesaling
Customer
1. Repeat orders
1. Repeat orders (small batches)
UniChem
Manufacturing Storage flow
Barts London NHS Trust
2. Daily deliveries
Repeat invoices
Physical Goods Flow
Document flow
30
Overall process flow manufacturing (creating
stock)
31
Overall process flow finished product to
pharmacy
32
System Workflow at Tjoapack
33
(No Transcript)
34
(No Transcript)
35
(No Transcript)
36
(No Transcript)
37
(No Transcript)
38
(No Transcript)
39
(No Transcript)
40
(No Transcript)
41
(No Transcript)
42
(No Transcript)
43
(No Transcript)
44
(No Transcript)
45
(No Transcript)
46
(No Transcript)
47
(No Transcript)
48
(No Transcript)
49
(No Transcript)
50
(No Transcript)
51
(No Transcript)
52
(No Transcript)
53
(No Transcript)
54
(No Transcript)
55
(No Transcript)
56
(No Transcript)
57
Conclusions Recommendations (1)
  • Supply chain wide traceability totally feasible
    with
  • Good planning resourcing
  • User commitment (senior level) and prioritisation
  • Easy to use, intuitive, robust user systems
  • Robust processes, tightly managed
  • Clear policy on integration with in-house systems
  • Good user training for all operatives involved
  • Full trading partner collaboration
    communication
  • However, business drivers/motivations different
    for different supply chain partners
    Government/Regulator regulation would help!!
  • Accordingly, In / Out data model might be a
    good place to start
  • Business Case varies according to supply chain
    role function
  • Clear patient safety benefits all parties buy-
    in to that
  • Electronic chain of custody (electronic pedigree)
    as counterfeit combatant
  • Recall Efficiency check-in efficiencies at the
    back door inventory management
  • financial reconciliation, recall systems are
    all integration dependent

58
Conclusions Recommendations (2)
  • Integration of traceability data into back office
    systems is key
  • For inventory management, exploiting batch
    expiry date data
  • For financial reconciliation order/goods
    received/invoice
  • For product recall
  • For traceability purposes product locations,
    sales made, consumption
  • But integration will require investment
    (considerable?)
  • But will vary from partner to partner
  • More research needed to determine precision of
    costs/benefit case
  • Focus on the traceability data, not the carrier
  • Data Matrix / RFID operates effectively in hybrid
    environment generally provided good quality
    reads

59
Conclusions Recommendations (3)
  • Inline production equipment installation is a
    complex, precise and resource intensive
    operation
  • Product packaging
  • must accommodate space for codes at time of
    design
  • colours must offer contrast for good reading
  • Pack handling is critical
  • Line configuration/equipment installation must
    allow firm base for encoding to avoid product
    wobble or other vibration
  • Presentation of pack to the printing device must
    be consistent incorrect shape and form can
    create poor quality printing/verification but
    get it right, very high print speeds can be
    achieved
  • Industry should get together and develop
    packaging standards
  • Related to pack handling printing
  • The case label
  • Beware unplanned pallet consolidation (for cost
    reduction)
  • Beware damage to Case Labels (e.g. by fork lift)

60
Conclusions Recommendations (4)
  • EPCglobal architecture (VeriSign) operated well
    for information gathering
  • But response issues for on-line product
    verification
  • EPCglobal standards should be reviewed to address
    this requirement
  • For the wholesaler, automating the A Frame
    (Automat) for high speed Tote box assembly is
    critical
  • Currently a road block for the wholesaler
  • More research needed here to determine technology
    needs

61
Plan for final months of the project
  • Completion of remaining deliverables
  • Delivery of the Dissemination Report (Q2 2009)
  • Continuing and increasing focus on
    information/experiences dissemination
  • Global audience
  • Publication of the Audio Visual
  • Preparation of articles, public presentation,
    case studies
  • Distribution of collateral
  • European conference platforms
  • Workshops and seminars
  • Website
  • Including Partner distribution channels

62
In Summary
  • The Pilot has been successful and met pre-set
    objectives
  • It has provided a very positive learning and
    proving environment
  • Huge amount of data collected for analysis
  • Invaluable hands-on knowledge and experience
    gained
  • Solid platform for future mass serialisation and
    traceability systems for Europe
  • Experiences and information gained will be
    available to all
  • see www.bridgewp6.eu/

63
BRIDGE WP6Thank You for taking the time to view
this presentation. For more information
including contact details of the Technology
Partners involved please see www.bridgewp6.eu
Write a Comment
User Comments (0)
About PowerShow.com